All News

2016

August

Media Release / Aug 30, 2016

FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases

Read More
Media Release / Aug 18, 2016

Launch of novel on-demand news service Transplant TODAY from TTS 2016 transplant congress

Read More

July

Media Release / Jul 19, 2016

Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects

Read More
Media Release / Jul 13, 2016

Sandoz biosimilar etanercept recommended by FDA advisory committee for approval to treat multiple inflammatory diseases

Read More
Media Release / Jul 07, 2016

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Read More

June

Media Release / Jun 20, 2016

Sandoz announces plans for five major global biosimilar launches by 2020

Read More
Media Release / Jun 09, 2016

New data demonstrates Sandoz' etanercept and rituximab biosimilar candidates bioequivalent to originator products

Read More

May

Media Release / May 24, 2016

Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency

Read More
Media Release / May 23, 2016

Ecuador earthquake recovery: Sandoz announces financial support and product donation

Read More

April

Media Release / Apr 29, 2016

Sandoz's Carol Lynch, Global Head Biopharmaceuticals is recognized in a Top 100 list, as the eighth most influential individual in medicine making

Read More